- Home
- WLGS vs SHPH Comparison
WLGS vs SHPH Comparison
Compare WLGS & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLGS
- SHPH
- Stock Information
- Founded
- WLGS 1981
- SHPH 2012
- Country
- WLGS Hong Kong
- SHPH United States
- Employees
- WLGS N/A
- SHPH N/A
- Industry
- WLGS Engineering & Construction
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- WLGS Consumer Discretionary
- SHPH Health Care
- Exchange
- WLGS Nasdaq
- SHPH Nasdaq
- Market Cap
- WLGS 22.2M
- SHPH 3.3M
- IPO Year
- WLGS 2023
- SHPH 2022
- Fundamental
- Price
- WLGS $2.58
- SHPH $1.41
- Analyst Decision
- WLGS
- SHPH
- Analyst Count
- WLGS 0
- SHPH 0
- Target Price
- WLGS N/A
- SHPH N/A
- AVG Volume (30 Days)
- WLGS 269.6K
- SHPH 43.1K
- Earning Date
- WLGS 11-14-2024
- SHPH 11-12-2024
- Dividend Yield
- WLGS N/A
- SHPH N/A
- EPS Growth
- WLGS N/A
- SHPH N/A
- EPS
- WLGS N/A
- SHPH N/A
- Revenue
- WLGS $6,825,879.00
- SHPH N/A
- Revenue This Year
- WLGS N/A
- SHPH N/A
- Revenue Next Year
- WLGS N/A
- SHPH N/A
- P/E Ratio
- WLGS N/A
- SHPH N/A
- Revenue Growth
- WLGS 63.69
- SHPH N/A
- 52 Week Low
- WLGS $0.40
- SHPH $1.03
- 52 Week High
- WLGS $4.20
- SHPH $4.94
- Technical
- Relative Strength Index (RSI)
- WLGS 58.66
- SHPH 49.84
- Support Level
- WLGS $2.33
- SHPH $1.12
- Resistance Level
- WLGS $4.20
- SHPH $1.26
- Average True Range (ATR)
- WLGS 0.65
- SHPH 0.11
- MACD
- WLGS 0.04
- SHPH 0.06
- Stochastic Oscillator
- WLGS 34.29
- SHPH 68.09
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.